CN112645883B - Preparation method of 3,6-dichloropyridazine - Google Patents

Preparation method of 3,6-dichloropyridazine Download PDF

Info

Publication number
CN112645883B
CN112645883B CN202011537250.0A CN202011537250A CN112645883B CN 112645883 B CN112645883 B CN 112645883B CN 202011537250 A CN202011537250 A CN 202011537250A CN 112645883 B CN112645883 B CN 112645883B
Authority
CN
China
Prior art keywords
dichloropyridazine
reaction
dihydroxypyridazine
chlorosuccinimide
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011537250.0A
Other languages
Chinese (zh)
Other versions
CN112645883A (en
Inventor
张来平
刘磊
朱林飞
魏莉
杜慧成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianhe Pharmaceutical Co ltd
Original Assignee
Tianhe Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianhe Pharmaceutical Co ltd filed Critical Tianhe Pharmaceutical Co ltd
Priority to CN202011537250.0A priority Critical patent/CN112645883B/en
Publication of CN112645883A publication Critical patent/CN112645883A/en
Application granted granted Critical
Publication of CN112645883B publication Critical patent/CN112645883B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the technical field of medicines, and particularly relates to a preparation method of 3,6-dichloropyridazine, which comprises the following steps: 5363 the production of 3,6-dichloropyridazine by chlorination of 3,6-dihydroxypyridazine and N-chlorosuccinimide; the chlorination reaction route is as follows:

Description

Preparation method of 3,6-dichloropyridazine
Technical Field
The invention belongs to the technical field of medicines, and relates to a preparation method of 3,6-dichloropyridazine.
Background
3,6-dichloropyridazine is an important pharmaceutical intermediate, published in Guangzhou chemical journal, vol.40, no. 9, 5.2012, xin Lei, et al: in the research of microwave synthesis of 3-amino-6-chloropyridazine, a preparation method of 3,6-dichloropyridazine is disclosed, which comprises the following steps:
(1) 8978 Synthesis of zxft 8978-dihydroxypyridazine:
a500 ml three-necked flask was charged with 72.5ml of hydrazine hydrate (80%) (1.3 mol), 120ml of 30% hydrochloric acid was added dropwise, 98g of maleic anhydride (1 mol) was added thereto, and the mixture was refluxed at 110 ℃ for 3 hours. Cooling, crystallizing, suction filtering to obtain yellow-white solid, washing the filter cake with cold ethanol 3-4 times, collecting white solid 3,6-dihydroxypyridazine 100g, yield 91%, m.p. 298-300 deg.C.
(2) Synthesis of 3,6-dichloropyridazine:
22g of 3, 6-dihydroxypyridazine (0.2 mol) and 232.8g of phosphorus pentachloride (1.12 mol) were charged in a three-necked flask, and heated to 125 ℃ for reaction for 4 hours. The generated phosphorus oxychloride is evaporated under reduced pressure, the obtained product is cooled to room temperature, and the coffee viscous liquid remained in the three-neck flask is poured into water for quenching. 28% ammonia water is added dropwise to adjust the pH value to about 8. The brown solid was suction filtered, the filtrate was extracted with dichloromethane, dried over anhydrous sodium sulfate, the dichloromethane was distilled off to give a solid, and the solids were combined. Recrystallizing with n-hexane to obtain white 3,6-dichloropyridazine crystal 24.4g, yield 82%, melting point m.p.67-69 deg.C.
The traditional process for preparing 3,6-dichloropyridazine needs to use a chlorinating agent which is usually phosphorus oxychloride, thionyl chloride, chlorine, phosphorus trichloride or phosphorus pentachloride, and has the following problems:
firstly, the use of phosphorus oxychloride, thionyl chloride, chlorine, phosphorus trichloride or phosphorus pentachloride inevitably results in the generation of hydrogen chloride, which causes serious environmental pollution.
Secondly, phosphorus oxychloride, thionyl chloride, chlorine, phosphorus trichloride or phosphorus pentachloride, highly toxic chemicals, the reaction temperature is high, and the process risk is high.
Thirdly, phosphorus oxychloride is used, a large amount of toluene or dichloromethane is needed for extracting products, the environmental pollution is large, and the cost is high.
Fourthly, the reaction of 3,6-dihydroxypyridazine to 3,6-dichloropyridazine through chlorination belongs to substitution reaction of hydroxyl, phosphorus trichloride generally used in the reaction of substitution of hydroxyl by chlorine atoms is easy to generate side reaction of phosphite ester, and phosphorus pentachloride can generate a large amount of side by-product phosphorus oxychloride; the NCS used in the invention is a more convenient electrophilic addition and electrophilic substitution reagent, has less process impurities, safer and simpler process operation and is more environment-friendly.
Disclosure of Invention
The invention aims to provide a preparation method of 3,6-dichloropyridazine, which solves the technical problems of large environmental pollution, large process risk and high cost of the conventional preparation method of 3,6-dichloropyridazine by adopting a traditional chlorinating agent.
In order to solve the technical problems, the invention adopts the following technical scheme that the preparation method of 3,6-dichloropyridazine is characterized by comprising the following steps: 3,6-dihydroxypyridazine and N-chlorosuccinimide are subjected to chlorination reaction to generate 3,6-dichloropyridazine;
the reaction route is as follows:
Figure BDA0002853471500000021
by adopting the technical scheme, the method has the following beneficial effects: the invention selects the N-chlorosuccinimide NCS to replace phosphorus oxychloride as the raw material, the production process is safer and more efficient, and the operation is safer and more environment-friendly.
In order to solve the technical problem of how to specifically prepare 3,6-dichloropyridazine, the invention adopts the following technical scheme, and the preparation method of 3,6-dichloropyridazine comprises the following steps:
(1) Ethanol, 3,6-dihydroxypyridazine and hydrochloric acid in a reaction vessel; heating and stirring;
(2) And continuously adding N-chlorosuccinimide NCS into the reaction vessel, controlling the temperature to react, cooling and crystallizing, and filtering to obtain a filter cake, namely 3,6-dichloropyridazine.
By adopting the technical scheme, the method has the following beneficial effects:
(1) The invention prepares 3,6-dichloropyridazine from N-chlorosuccinimide NCS and 3,6-dihydroxypyridazine, the process has simple steps and simple operation, and the by-product succinimide in the process can be recovered by distilling and recovering ethanol. Less environmental pollution and higher product purity, and is more beneficial to industrial production.
(2) The N-chlorosuccinimide NCS is adopted as a chlorinating agent, so that the character is stable and the toxicity is low.
(3) The N-chlorosuccinimide NCS is adopted as a chlorinating agent, the chlorination reaction condition is mild, the product extraction is simple, and only suction filtration or centrifugation is needed.
(4) The product produced by crystallization by the preparation method has good product quality, and the product yield is more than 89.8 percent and reaches 92.6 percent at most; the purity of the product is over 99.3 percent and reaches 99.5 percent at most.
In order to solve the technical problem that 3,6-dihydroxypyridazine is completely reacted incompletely, the invention adopts the following technical scheme that the molar ratio of 3,6-dihydroxypyridazine to N-chlorosuccinimide NCS is 1: (2.05-2.1), the slight excess of NCS can make 3,6-dihydroxypyridazine completely react, and simultaneously, the waste of NCS is avoided.
In order to solve the technical problems of more impurities and low yield of the existing preparation method, the invention adopts the following technical scheme that the weight ratio of 3,6-dihydroxypyridazine to ethanol is 1: (2-4), not only can ensure that the main impurity succinimide is completely dissolved, but also can ensure that the product is dissolved in the main impurity succinimide as little as possible.
In order to solve the technical problem of poor process safety of the existing preparation method, the invention adopts the following technical scheme that the weight ratio of 3,6-dihydroxypyridazine to hydrochloric acid is 1: (0.09-0.11) can sufficiently promote the reaction to be stably carried out, and unsafe phenomena such as material aggregation, rapid temperature rise and the like are avoided.
In order to solve the technical problem of poor process safety of the existing preparation method, the invention adopts the following technical scheme that when the N-chlorosuccinimide NCS is added, the temperature is controlled to be 40-45 ℃, and unsafe factors caused by over-high reaction rate and over-high heat release can be effectively avoided.
In order to solve the technical problems of more impurities and lower yield of the existing preparation method, the invention adopts the following technical scheme that the reaction temperature in the step (2) is not more than 60 ℃ and the time is 1-3 hours, so that the impurity increase caused by overhigh temperature can be effectively avoided, and the impurity increase caused by incomplete reaction and overlong reaction time can be effectively avoided by controlling the reaction time.
In order to solve the technical problems of more impurities and lower yield of the existing preparation method, the invention adopts the following technical scheme that the crystallization temperature is 5-10 ℃, the crystallization time is 1-3 hours, so that the product can be fully crystallized, and the separation of impurities is avoided.
In order to solve the technical problem of more impurities in the existing preparation method, the invention adopts the following technical scheme that the drying mode of the filter cake is vacuum drying, the vacuum drying temperature is 40-50 ℃, the vacuum degree is-0.08 MPa to-0.1 MPa, and the vacuum drying time is 3-5 hours.
In order to solve the technical problem that the reaction speed of the N-chlorosuccinimide is too high, the invention adopts the following technical scheme that the N-chlorosuccinimide is put into a reaction vessel in 3-5 batches, the weight of each batch is equivalent, the difference is not too large, the reaction speed is effectively prevented from being too high, and the reaction is ensured to be complete.
Detailed Description
The present invention will be further described with reference to the following examples.
Example 1:
27g of ethanol is added into a 250ml reaction bottle, and stirring is started; adding 3,6-dihydroxypyridazine 9g and hydrochloric acid 0.9g; heating to 40 ℃; adding 22.4g NCS (N-chlorosuccinimide) into a reaction bottle for 3 times, wherein the temperature of the NCS is 40-45 ℃ every time, and the temperature is not more than 60 ℃ in the reaction process; after the NCS feeding is finished, controlling the temperature to be 45-55 ℃ and reacting for 2 hours; cooling the reaction liquid to 5-10 ℃, then starting timing crystallization for 2 hours, carrying out suction filtration, and leaching a filter cake with a small amount of absolute ethyl alcohol; the filter cake is dried for 4 hours in vacuum at 40-50 ℃ and the vacuum degree of minus 0.09 MPa; 10.7g of a white solid was obtained, the calculated yield was 89.8%, the purity (99.3%), the melting point was 68.2-68.7 ℃ (document 68-69 ℃).
Example 2:
adding 180g of ethanol into a 5L reaction bottle, and starting stirring; then 3,6-dihydroxypyridazine 90g and hydrochloric acid 9g are put in; heating to 40 ℃; adding 222.1g of NCS (N-chlorosuccinimide) into a reaction bottle for 5 times, wherein the temperature of the NCS is 40-45 ℃ every time, and the temperature is not more than 60 ℃ in the reaction process; after the NCS feeding is finished, controlling the temperature to be 45-55 ℃ and reacting for 2 hours; cooling the reaction liquid to 5-10 ℃, then starting timing crystallization for 2 hours, carrying out suction filtration, and leaching a filter cake with a small amount of absolute ethyl alcohol; vacuum drying the filter cake for 4 hours at 40-50 ℃ under the vacuum degree of-0.09 MPa; 110.4g of white solid is obtained, the calculated yield is 92.6%, the purity is 99.5%, and the melting point is 68.2-68.8 ℃ (68-69 ℃ in the literature).
Example 3:
adding 7.2kg of ethanol into a 10L reaction bottle, and starting stirring; then 3,6-dihydroxypyridazine 1.8kg and hydrochloric acid 180g are added; heating to 40 ℃; adding 4.40kg of NCS (N-chlorosuccinimide) into a reaction bottle for 5 times, wherein the temperature of the NCS is 40-45 ℃ every time, and the temperature is not more than 60 ℃ in the reaction process; after the NCS feeding is finished, controlling the temperature to be 45-55 ℃ and reacting for 2 hours; cooling the reaction liquid to 5-10 ℃, then starting timing crystallization for 2 hours, carrying out suction filtration, and leaching a filter cake with a small amount of absolute ethyl alcohol; the filter cake is dried for 4 hours in vacuum at 40-50 ℃ and the vacuum degree of minus 0.09 MPa; 2.18kg of a white solid was obtained, and the calculated yield was 91.0%, the purity (99.4%), and the melting point was 68.3 to 68.7 ℃ (document 68 to 69 ℃).

Claims (6)

1. A preparation method of 3,6-dichloropyridazine is characterized by comprising the following steps: 3,6-dihydroxypyridazine and N-chlorosuccinimide are subjected to chlorination reaction to generate 3,6-dichloropyridazine;
the preparation method comprises the following steps:
(1) Adding ethanol, 3,6-dihydroxypyridazine and hydrochloric acid into a reaction container, and heating and stirring; the weight ratio of 3,6-dihydroxypyridazine to ethanol is 1: (2-4); the weight ratio of 3,6-dihydroxypyridazine to hydrochloric acid is 1: (0.09-0.11);
(2) Continuously adding N-chlorosuccinimide into the reaction container, carrying out chlorination reaction, cooling and crystallizing, and carrying out suction filtration to obtain a filter cake, namely 3,6-dichloropyridazine; the mole ratio of 3,6-dihydroxypyridazine to N-chlorosuccinimide is 1: (2.05-2.1);
the chlorination reaction route is as follows:
Figure FDA0003826785390000011
2. the method for preparing 3,6-dichloropyridazine according to claim 1, wherein the temperature for continuously adding N-chlorosuccinimide into the reaction vessel is controlled to be 40-45 ℃.
3. The process for preparing 3,6-dichloropyridazine according to claim 1, wherein the chlorination reaction temperature in step (2) is not more than 60 ℃ and the chlorination reaction time is 1-3 hours.
4. The process for preparing 3,6-dichloropyridazine according to claim 1, wherein the crystallization temperature is 5 to 10 ℃ and the crystallization time is 1 to 3 hours.
5. The preparation method of 3,6-dichloropyridazine according to claim 1, wherein the filter cake is vacuum dried at 40-50 ℃ under a vacuum degree of-0.08 MPa-0.1 MPa for 3-5 hours.
6. The method for preparing 3,6-dichloropyridazine according to claim 1, wherein the N-chlorosuccinimide is added to the reaction vessel in 3 to 5 portions.
CN202011537250.0A 2020-12-23 2020-12-23 Preparation method of 3,6-dichloropyridazine Active CN112645883B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011537250.0A CN112645883B (en) 2020-12-23 2020-12-23 Preparation method of 3,6-dichloropyridazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011537250.0A CN112645883B (en) 2020-12-23 2020-12-23 Preparation method of 3,6-dichloropyridazine

Publications (2)

Publication Number Publication Date
CN112645883A CN112645883A (en) 2021-04-13
CN112645883B true CN112645883B (en) 2022-10-25

Family

ID=75359501

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011537250.0A Active CN112645883B (en) 2020-12-23 2020-12-23 Preparation method of 3,6-dichloropyridazine

Country Status (1)

Country Link
CN (1) CN112645883B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113698355B (en) * 2021-08-30 2023-05-26 郑州华赞医药科技有限公司 Synthesis method of 4, 5-dihydroxypyridazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1037467A (en) * 1973-09-04 1978-08-29 Takayuki Naito 7-(.alpha.-(2-AMINOMETHYL-1-CYCLOHEXENYL AND 1,4-CYCLOHEXADIENYL)-ACETAMIDO)-3-HETEROCYCLICTHIOMETHYL-3-CEPHEM-4-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF
CN104447569A (en) * 2014-11-05 2015-03-25 定陶县友帮化工有限公司 Method for synthetizing 3,6-dichloropyridazine

Also Published As

Publication number Publication date
CN112645883A (en) 2021-04-13

Similar Documents

Publication Publication Date Title
CN112645883B (en) Preparation method of 3,6-dichloropyridazine
CN110551023A (en) Method for preparing alkyl diacid monobenzyl ester
CN110790721B (en) Synthetic method of ceftazidime side chain ethyl ester
US4647689A (en) Preparation of alkyl trifluoroacetoacetate
CN108358900A (en) A kind of preparation method of Afatinib and its maleate
CN113227058A (en) Improved process for preparing 4, 6-dihydroxypyrimidine
CN107540648A (en) A kind of preparation method of Dapagliflozin
CN101508678B (en) Process for preparing 2-methyl-4-amino-5-acetyl aminomethyl pyrimidine
CN115557928A (en) Synthetic method of 2-chlorothiophene-5-formic acid
CN112341313B (en) Preparation method of 3, 5-dichlorobenzyl alcohol and carboxyamidotriazole intermediate
EP0006606B1 (en) Process for the preparation of carbazoles and intermediates therefor
CN114478837A (en) Preparation method of sugammadex sodium derivative
CN111303040A (en) Method for preparing imidazole-1-acetic acid by one-pot method
CN111233835A (en) Preparation and purification method of 5- (2-fluorophenyl) -1- (pyridine-3-ylsulfonyl) -1H-pyrrole-3-formaldehyde
IE47939B1 (en) Process for the manufacture of aluminium monoethyl-phosphite
CN112778196B (en) Preparation method of vitamin B6
KR840000115B1 (en) Process for the preparation of a carbazole derivative
CN116375562B (en) Refining method for preparing isoborneol by camphene hydration
CN113480574B (en) Recycling method of phosphorus-containing compound salt
CN115850199B (en) Preparation method of high-purity sodium sulfaisoxazole
CN114213249B (en) Synthesis method of dolutegravir intermediate
CN117917397A (en) Method for synthesizing N, N-dihydroxymethyl tert-butylamine
CN118812326A (en) Preparation method of 3-chloro-1-propanol
CN114621228A (en) Preparation method of 2-amino-6-chloropurine
CN116836056A (en) Process for preparing dimethyl 1, 2-dimethylcyclopropane-1, 2-dicarboxylate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 225200 No.86 Shuangshu Road, Xiannv Town, Jiangdu District, Yangzhou City, Jiangsu Province

Applicant after: Tianhe Pharmaceutical Co.,Ltd.

Address before: 225200 No.86 Shuangshu Road, Xiannv Town, Jiangdu District, Yangzhou City, Jiangsu Province

Applicant before: YANGZHOU TIANHE PHARMACEUTICAL Co.,Ltd.

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address

Address after: 225200 No.86 Shuangshu Road, Xiannv Town, Jiangdu District, Yangzhou City, Jiangsu Province

Patentee after: Tianhe Pharmaceutical Co.,Ltd.

Country or region after: China

Address before: 225200 No.86 Shuangshu Road, Xiannv Town, Jiangdu District, Yangzhou City, Jiangsu Province

Patentee before: Tianhe Pharmaceutical Co.,Ltd.

Country or region before: China

CP03 Change of name, title or address